Pretreatment by Evodiamine is Neuroprotective in Cerebral Ischemia: Up-Regulated pAkt, pGSK3β, Down-Regulated NF-κB Expression, and Ameliorated BBB Permeability

[1]  S. Ryter,et al.  Carbon Monoxide Protects against Hepatic Ischemia/Reperfusion Injury via ROS-Dependent Akt Signaling and Inhibition of Glycogen Synthase Kinase 3β , 2013, Oxidative medicine and cellular longevity.

[2]  M. Jabłoński,et al.  Sporadic Alzheimer’s Disease Begins as Episodes of Brain Ischemia and Ischemically Dysregulated Alzheimer’s Disease Genes , 2013, Molecular Neurobiology.

[3]  L. Cui,et al.  Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice , 2013, Brain Research.

[4]  S. Shyue,et al.  Essential role of transient receptor potential vanilloid type 1 in evodiamine‐mediated protection against atherosclerosis , 2013, Acta physiologica.

[5]  Xiaoling Zhang,et al.  Protection by silibinin against experimental ischemic stroke: Up-regulated pAkt, pmTOR, HIF-1α and Bcl-2, down-regulated Bax, NF-κB expression , 2012, Neuroscience Letters.

[6]  Xiaoling Zhang,et al.  Beneficial effects of sulindac in focal cerebral ischemia: A positive role in Wnt/β-catenin pathway , 2012, Brain Research.

[7]  Xiaoling Zhang,et al.  The protection by Octreotide against experimental ischemic stroke: Up-regulated transcription factor Nrf2, HO-1 and down-regulated NF-κB expression , 2012, Brain Research.

[8]  Linyu Chen,et al.  Neuroprotective effect of early and short-time applying sophoridine in pMCAO rat brain: Down-regulated TRAF6 and up-regulated p-ERK1/2 expression, ameliorated brain infaction and edema , 2012, Brain Research Bulletin.

[9]  H. Qiao,et al.  The Intrinsic PEDF is Regulated by PPARγ in Permanent Focal Cerebral Ischemia of Rat , 2012, Neurochemical Research.

[10]  Xiaoling Zhang,et al.  Neuroprotection of early and short-time applying berberine in the acute phase of cerebral ischemia: Up-regulated pAkt, pGSK and pCREB, down-regulated NF-κB expression, ameliorated BBB permeability , 2012, Brain Research.

[11]  Muhammad Khan,et al.  Cytotoxic effect of evodiamine in SGC-7901 human gastric adenocarcinoma cells via simultaneous induction of apoptosis and autophagy. , 2012, Oncology reports.

[12]  Xiangjian Zhang,et al.  Polydatin modulates inflammation by decreasing NF-κB activation and oxidative stress by increasing Gli1, Ptch1, SOD1 expression and ameliorates blood–brain barrier permeability for its neuroprotective effect in pMCAO rat brain , 2012, Brain Research Bulletin.

[13]  Hui Chen,et al.  Enhanced Antitumor Efficacy of Gemcitabine by Evodiamine on Pancreatic Cancer via Regulating PI3K/Akt Pathway , 2011, International journal of biological sciences.

[14]  Wei Du,et al.  Neuroprotection and underlying mechanisms of oxymatrine in cerebral ischemia of rats , 2011, Neurological research.

[15]  Kai Gao,et al.  Evodiamine improves congnitive abilities in SAMP8 and APPswe/PS1ΔE9 transgenic mouse models of Alzheimer's disease , 2011, Acta Pharmacologica Sinica.

[16]  Wei Du,et al.  Tanshinone II A down-regulates HMGB1, RAGE, TLR4, NF-κB expression, ameliorates BBB permeability and endothelial cell function, and protects rat brains against focal ischemia , 2010, Brain Research.

[17]  Y. Liu,et al.  Oxymatrine Downregulates TLR4, TLR2, MyD88, and NF-κB and Protects Rat Brains against Focal Ischemia , 2010, Mediators of inflammation.

[18]  M. Jabłoński,et al.  Alzheimer's Mechanisms in Ischemic Brain Degeneration , 2009, Anatomical record.

[19]  C. Teng,et al.  EVODIAMINE REPRESSES HYPOXIA-INDUCED INFLAMMATORY PROTEINS EXPRESSION AND HYPOXIA-INDUCIBLE FACTOR 1&agr; ACCUMULATION IN RAW264.7 , 2009, Shock.

[20]  Y. Liu,et al.  Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia , 2009, Brain Research.

[21]  Sook-Kyoung Heo,et al.  Evodiamine and rutaecarpine inhibit migration by LIGHT via suppression of NADPH oxidase activation , 2009, Journal of cellular biochemistry.

[22]  Y. Liu,et al.  Oxymatrine protects rat brains against permanent focal ischemia and downregulates NF-κB expression , 2009, Brain Research.

[23]  J. Kong,et al.  Quetiapine regulates neurogenesis in ischemic mice by inhibiting NF-κB p65/p50 expression , 2009, Neurological research.

[24]  Yuan Zhang,et al.  Intragastric administration of evodiamine suppresses NPY and AgRP gene expression in the hypothalamus and decreases food intake in rats , 2009, Brain Research.

[25]  C. Thiemermann,et al.  Insulin Reduces Cerebral Ischemia/Reperfusion Injury in the Hippocampus of Diabetic Rats , 2009, Diabetes.

[26]  J. Yi,et al.  Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage , 2007, Neurochemistry International.

[27]  Michiyasu Suzuki,et al.  Cilostazol inhibits the redistribution of the actin cytoskeleton and junctional proteins on the blood-brain barrier under hypoxia/reoxygenation. , 2007, Pharmacological research.

[28]  Y. Yoo,et al.  Caspase-dependent and caspase-independent apoptosis induced by evodiamine in human leukemic U937 cells , 2006, Molecular Cancer Therapeutics.

[29]  K. Pennypacker,et al.  NF-κB protects neurons from ischemic injury after middle cerebral artery occlusion in mice , 2006, Brain Research.

[30]  R. Jope,et al.  Toll-like receptor–mediated cytokine production is differentially regulated by glycogen synthase kinase 3 , 2005, Nature Immunology.

[31]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[32]  S. Bao,et al.  The activation of Akt/PKB signaling pathway and cell survival , 2005, Journal of cellular and molecular medicine.

[33]  M. Yenari,et al.  Post-ischemic inflammation: molecular mechanisms and therapeutic implications , 2004, Neurological research.

[34]  Jun Peng,et al.  Protective Effects of Evodiamine on Myocardial Ischemia-Reperfusion Injury in Rats , 2004, Planta medica.

[35]  G. Steinberg,et al.  Glycogen synthase kinase 3β inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia , 2004, Experimental Neurology.

[36]  M. Karjalainen‐Lindsberg,et al.  Nuclear Factor- (cid:1) B Contributes to Infarction After Permanent Focal Ischemia , 2004 .

[37]  P. Sen,et al.  Involvement of the Akt/PKB signaling pathway with disease processes , 2003, Molecular and Cellular Biochemistry.

[38]  Y. Yamori,et al.  Antioxidant nutrients and hypoxia/ischemia brain injury in rodents. , 2003, Toxicology.

[39]  K. Jin,et al.  VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. , 2003, The Journal of clinical investigation.

[40]  Mercedes Alonso,et al.  Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation , 2002, Medicinal research reviews.

[41]  R. Jope,et al.  The multifaceted roles of glycogen synthase kinase 3β in cellular signaling , 2001, Progress in Neurobiology.

[42]  K. Frei,et al.  Molecular and cellular permeability control at the blood–brain barrier , 2001, Brain Research Reviews.

[43]  P. Cohen,et al.  The renaissance of GSK3 , 2001, Nature Reviews Molecular Cell Biology.

[44]  S. Tsukita,et al.  Endothelial Claudin , 1999, The Journal of cell biology.

[45]  C. Coutelle,et al.  In utero gene therapy: The case for , 1999, Nature Medicine.

[46]  C. Sotak,et al.  A novel endothelin antagonist, A-127722, attenuates ischemic lesion size in rats with temporary middle cerebral artery occlusion: a diffusion and perfusion MRI study. , 1998, Stroke.

[47]  R. Pluta,et al.  Early blood-brain barrier changes in the rat following transient complete cerebral ischemia induced by cardiac arrest , 1994, Brain Research.

[48]  T. Nowak,et al.  Cerebral Vascular Volume after Repeated Ischemic Insults in the Gerbil: Comparison with Changes in CBF and Brain Edema , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[49]  G. Rosenberg,et al.  MMP-mediated disruption of claudin-5 in the blood-brain barrier of rat brain after cerebral ischemia. , 2011, Methods in molecular biology.

[50]  R. Keep,et al.  Tracing the endocytosis of claudin-5 in brain endothelial cells. , 2011, Methods in molecular biology.

[51]  K. Borowicz,et al.  Role of nuclear factor kappaB in the central nervous system. , 2007, Pharmacological reports : PR.

[52]  A. Baldwin,et al.  Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription. , 2005, Molecular and cellular biology.

[53]  G. Steinberg,et al.  Glycogen synthase kinase 3beta inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia. , 2004, Experimental neurology.

[54]  A. Martin-Villalba,et al.  NF-kappaB is activated and promotes cell death in focal cerebral ischemia. , 1999, Nature medicine.

[55]  J. Tseng,et al.  The effect of Evodia rutaecarpa extract on cytokine secretion by human mononuclear cells in vitro. , 1995, The American Journal of Chinese Medicine.

[56]  P. Weinstein,et al.  Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989, Stroke.

[57]  E. ZLonga,et al.  Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989 .

[58]  Glycogen Synthase Kinase 3 (cid:2) Functions To Specify Gene-Specific, NF- (cid:3) B-Dependent Transcription , 2022 .